Top Companies in the Oxygen Concentrators

The oxygen concentrators market is forecasted to reach USD 1.71 billion by 2030, up from USD 1.27 billion in 2025, with a CAGR of 6.1%. The global increase in respiratory illnesses is a key driver of the oxygen concentrators market. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, pneumonia, pulmonary fibrosis, and post-COVID lung damage have consistently risen due to aging populations, urbanization, environmental pollution, and smoking. COPD alone ranks as the third leading cause of death worldwide, affecting over 300 million people globally. Additionally, rising public awareness about early respiratory care will likely boost the use of home oxygen therapy devices, like concentrators.

The leading players in the oxygen concentrators market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), TEIJIN LIMITED (Japan), DAIKIN INDUSTRIES, Ltd. (Japan), ESAB Corporation (GCE GROUP) (Switzerland), Caire, Inc. (US), React Health (Dublin), Precision Medical Inc. (US), Drive DeVilbiss Healthcare (US), and Nidek Medical Products, Inc. (US), among others. These companies have adopted various growth strategies, such as product launches, acquisitions, and expansion, to enhance their presence and reach in the oxygen concentrators market.

• In June 2025, Inogen, Inc. launched the Voxi 5 Stationary Oxygen Concentrator, which combines affordability with durability and sets a new standard in oxygen therapy. It is designed to improve access to high-quality oxygen therapy for long-term care patients in the US. It also introduced the Rove 4 Portable Oxygen Concentrator in October 2024, which offers the highest oxygen output in the lightest weight 4-setting POC. Rove 4 utilizes Inogen’s patented pulse-dose Intelligent Delivery Technology3. This technology provides unparalleled triggering sensitivity to quickly detect a breath and deliver oxygen within the first 250 milliseconds of inspiration, where oxygen most affects lung gas exchange.

To know about the assumptions considered for the study download the pdf brochure

Koninklijke Philips N.V.

Philips has established itself as a leading player in the oxygen concentrators market by offering a comprehensive range of respiratory care solutions, including stationary and portable ones. Its strategy emphasizes integrated technologies that combine real-time monitoring, smart alarms, and connectivity to improve patient outcomes and enable remote management. Philips leverages its strong global distribution network and strategic collaborations with healthcare providers to expand market reach. The company’s focus on user-friendly, compact designs helps reduce caregiver burden while enhancing patient comfort. Its ongoing investment in innovation and non-invasive respiratory technologies reinforces its leadership in home and clinical oxygen therapy solutions.

Inogen Inc.

Inogen Inc. has built a strong presence in the market by focusing on portable oxygen concentrators (POCs) designed for active, ambulatory patients. Its direct-to-consumer sales method, supported by digital marketing and home delivery, sets it apart from traditional B2B companies. Inogen emphasizes lightweight, battery-efficient devices that increase mobility and patient independence. Strategic R&D investments promote ongoing innovation, targeting improvements in flow settings, noise reduction, and wireless connectivity. Global expansion and the acquisition of complementary technologies and service providers strengthen its competitive edge. Inogen’s patient-centered approach continues to transform long-term oxygen therapy in home environments.

MARKET RANKING

The global oxygen concentrators market is highly consolidated, with leading companies holding over 70% of the total market share in 2024. Some key players dominating the market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), Caire, Inc. (US), and Drive DeVilbiss Healthcare (US)

The leading companies in the oxygen concentrators market are located in developed areas like North America, Europe, and the Asia Pacific. However, recently, several smaller companies focusing on oxygen concentrators have appeared in niche markets and are competing with global players in terms of product range and innovation. The promising growth opportunities in the Asia Pacific and Latin American markets are motivating market players to expand their presence in these regions.

Related Reports:

Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous and Pulse Flow), Flowrate (0-5L/Min, 5-10L/Min, Above 10L/Min), Application (Chronic Obstructive Pulmonary Disorder), End User (Home Care Settings) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com